2007
DOI: 10.1016/j.lfs.2007.09.008
|View full text |Cite
|
Sign up to set email alerts
|

Differential effects of quercetin and silymarin on arsenite-induced cytotoxicity in two human breast adenocarcinoma cell lines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
11
0

Year Published

2010
2010
2019
2019

Publication Types

Select...
6
2

Relationship

3
5

Authors

Journals

citations
Cited by 24 publications
(12 citation statements)
references
References 31 publications
1
11
0
Order By: Relevance
“…Unexpectedly, co-treatment with these compounds neutralised this effect, perhaps because it may depend on pharmacological interactions, though reciprocal chelation cannot be discarded (Mishra and Flora 2008). Such interactions are supported by our previous results about stress markers, which revealed different effects for Q alone and for As + Q co-exposure Soria et al 2007), which led to alterations in effectiveness and/or half-life, with different structure-dependent effects being found for Q and S (Tsujimoto et al 2009). Indeed, S exhibited antioxidant activity against the As-induced AHP increase without modifying the redox state of cells when it was administered alone.…”
Section: Discussionsupporting
confidence: 62%
“…Unexpectedly, co-treatment with these compounds neutralised this effect, perhaps because it may depend on pharmacological interactions, though reciprocal chelation cannot be discarded (Mishra and Flora 2008). Such interactions are supported by our previous results about stress markers, which revealed different effects for Q alone and for As + Q co-exposure Soria et al 2007), which led to alterations in effectiveness and/or half-life, with different structure-dependent effects being found for Q and S (Tsujimoto et al 2009). Indeed, S exhibited antioxidant activity against the As-induced AHP increase without modifying the redox state of cells when it was administered alone.…”
Section: Discussionsupporting
confidence: 62%
“…4. Doses used were selected based on previous experiments and published literature [61]. All biochemical studies were performed at day 40 (before the start of PUFAs treatment) designed as breastfeeding weaning period, it was previously suggested that both obesity and type 2 DM may have their origins in the perinatal period, and at the end of 6 and 12 months of age [62, 63].…”
Section: Methodsmentioning
confidence: 99%
“…Besides, As can react with protein and nonprotein thiol groups, leading to the alteration of signaling pathways, structural modifications, and enzyme inactivation [6], which may stimulate reactive oxygen species (ROS) production [5]. Oxidative stress is recognized as a possible mechanism implicated in both As-induced apoptosis and carcinogenicity [7,8]. The resistance to As toxicity in mammalian cells is correlated with higher levels of reduced glutathione (GSH) and GSH-related enzymes [5,6].…”
Section: Introductionmentioning
confidence: 99%